HORACE MANN EDUCATORS CORP /DE/ — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that HORACE MANN EDUCATORS CORP /DE/ filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.60B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.49B | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | $346.40M | Feb 27, 2024 |
| FY2023 | Sep 30, 2022 | $342.60M | Feb 27, 2024 |
| FY2023 | Jun 30, 2022 | $345.90M | Feb 27, 2024 |
| FY2023 | Mar 31, 2022 | $346.70M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $331.20M | Feb 27, 2024 |
| FY2023 | Sep 30, 2021 | $329.40M | Feb 27, 2024 |
| FY2023 | Jun 30, 2021 | $346.90M | Feb 27, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $162.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $102.80M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $45.00M | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | ($16.70M) | Feb 27, 2024 |
| FY2023 | Sep 30, 2022 | $20.40M | Feb 27, 2024 |
| FY2023 | Jun 30, 2022 | ($4.20M) | Feb 27, 2024 |
| FY2023 | Mar 31, 2022 | $20.30M | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $46.90M | Feb 27, 2024 |
| FY2023 | Sep 30, 2021 | $20.20M | Feb 27, 2024 |
| FY2023 | Jun 30, 2021 | $54.20M | Feb 27, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $553.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $452.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $302.10M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $171.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $204.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $259.80M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $127.60M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $200.89M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $256.59M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $211.43M | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.27B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $14.49B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $14.05B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $13.31B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $14.46B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $13.47B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $12.48B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $11.03B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $11.20B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $10.58B | Mar 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $13.78B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $13.20B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $12.87B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $12.21B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $12.58B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $11.68B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $10.91B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $9.74B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $9.70B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $9.28B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.48B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.18B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.50B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $1.79B | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $1.57B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.29B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.50B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $1.29B | Mar 1, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $54.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $54.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $54.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $43.50M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $43.50M | Feb 27, 2024 |
| FY2022 | Dec 31, 2019 | $49.10M | Feb 28, 2023 |
| FY2019 | Dec 31, 2018 | $47.40M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $47.40M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $47.40M | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.65B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.55B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.50B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.51B | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $1.52B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.43B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.35B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.22B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $1.23B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $1.16B | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $38.10M | Feb 27, 2026 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $593.40M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $547.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $546.00M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $249.00M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $253.60M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $302.30M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $298.03M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $297.74M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $297.47M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $247.21M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
| FY2023 | Sep 30, 2021 | 0 | Feb 27, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Feb 27, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 3 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 27, 2026 |
| FY2023 | Dec 31, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | 1 | Feb 27, 2024 |
| FY2023 | Sep 30, 2021 | 0 | Feb 27, 2024 |
| FY2023 | Jun 30, 2021 | 1 | Feb 27, 2024 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.10M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $55.50M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $53.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $52.60M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $51.40M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $49.60M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $47.30M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $46.69M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $46.11M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $44.31M | Mar 1, 2019 |